National and Kapodistrian University of Athens
Network signature techniques for drug discovery in pulmonary fibrosis
Abstract
dc:descriptionFibrotic diseases cover a spectrum of systemic and organ specific diseases that affect a large portion of the population, currently without cure. Idiopathic Pulmonary Fibrosis (IPF) is an interstitial disease as well as one of the most common and studied fibrotic diseases which still remains an active research target. Understanding the underlying biological mechanisms and respective interactions of a disease remains an elusive, time consuming and costly task. Computational methodologies that propose communities and reveal respective relationships can be of great value as they can help expedite the process of identifying how perturbations in a single can affect other pathways. Drug or Drug Repositioning (DR) is a methodology where already existing drugs are tested against diseases outside their initial spectrum to reduce the high cost and long periods of new drug development. The 4 main objectives of this PhD thesis is to (i) identify key differentially expressed genes of fibrotic diseases, (ii) explore the respective perturbed biological pathways and (iii) suggest repurposed drugs as potential anti-fibrotic candidates for further testing and (iv) identify which fibrotic diseases resemble based on common terms, to potentially pursue common regimens. We analyze transcriptomics datasets containing fibrotic and normal samples to identify key genes that are implicated in fibrotic diseases. We use these genes as input in DR tools and then propose a novel drug re-ranking methodology via a scoring formula that consolidates standard scores with structural, functional and side effect scores. Following, we present a analysis and community detection methodology, based on Random Walk theory, where a walker crosses a pathway-to-pathway network under the guidance of a disease-related map. The latter is a gene network that we construct by integrating multi-source information regarding a specific disease. The most frequent trajectories highlight communities of pathways that are expected to be strongly related to the disease under study. By applying our pathway analysis methodology on 9 different fibrotic maladies, we identify various common highlighted pathways as well as unique entries for some of the diseases.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2020
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Karatzas, Evangelos
- Καρατζάς, Ευάγγελος
Subjects
dc:subject × 14- Ιδιοπαθής πνευμονική ίνωση
- Επαναπροσδιορισμός φαρμάκων
- Γονιδιακή έκφραση
- Βιολογικά μονοπάτια
- Χημική σύσταση
- Idiopathic pulmonary fibrosis
- Drug repurposing
- Gene expression
- Biological pathways
- Chemical structures
- Ιατρική και Επιστήμες Υγείας
- Επιστήμες Υγείας
- Medical and Health Sciences
- Health Sciences
Rights
dc:rights- Statement dc:rights
-
- BY
- Language dc:language
- eng
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/47361